SECUKINUMAB SIGNIFICANTLY IMPROVES ASAS20 RESPONSES VERSUS PLACEBO IN MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS PATIENTS
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY(2012)
关键词
ankylosing spondylitis patients,asas20 responses,moderate-to-severe
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要